BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36474663)

  • 1. A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients.
    Taylor JK; Mady LJ; Baddour K; Iheagwara UK; Zhai S; Ohr JP; Zandberg DP; Gorantla VC; Ferris RL; Kim S; Duvvuri U; Kubik MW; Sridharan S; Johnson JT; Holeva KD; Quinn AE; Clump DA
    World J Otorhinolaryngol Head Neck Surg; 2022 Dec; 8(4):345-354. PubMed ID: 36474663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of oral mucositis in advanced oral squamous cell carcinoma patients managed with prophylactic photobiomodulation therapy-insights for future protocol development.
    de Pauli Paglioni M; Faria KM; Palmier NR; Prado-Ribeiro AC; E Dias RB; da Graça Pinto H; Treister NS; Epstein JB; Migliorati CA; Santos-Silva AR; Brandão TB
    Lasers Med Sci; 2021 Mar; 36(2):429-436. PubMed ID: 32627112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
    Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
    Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photobiomodulation reduces the impact of radiotherapy on oral health-related quality of life due to mucositis-related symptoms in head and neck cancer patients.
    Martins AFL; Morais MO; de Sousa-Neto SS; de Jesus APG; Nogueira TE; Valadares MC; Freitas NMA; Batista AC; Leles CR; Mendonça EF
    Lasers Med Sci; 2021 Jun; 36(4):903-912. PubMed ID: 33113075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial.
    Kauark-Fontes E; Migliorati CA; Epstein JB; Treister NS; Alves CGB; Faria KM; Palmier NR; Rodrigues-Oliveira L; de Pauli Paglioni M; Gueiros LAM; da Conceição Vasconcelos KGM; de Castro G; Leme AFP; Lopes MA; Prado-Ribeiro AC; Brandão TB; Santos-Silva AR
    Support Care Cancer; 2022 Mar; 30(3):2225-2236. PubMed ID: 34708311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
    Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of photobiomodulation therapy in the management of oral mucositis in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled trials.
    Shen B; Zhou Y; Wu D; Liu J
    Head Neck; 2024 Apr; 46(4):936-950. PubMed ID: 38265122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal of a prophylactic photobiomodulation protocol for chemotherapy-induced oral and oropharyngeal mucositis: a randomized clinical trial.
    Heimlich FV; de Arruda JAA; Pereira NM; Faria LDS; Abreu LG; Ferreira MVL; Kakehasi FM; Travassos DV; Silva TA; Mesquita RA
    Lasers Med Sci; 2023 Oct; 38(1):245. PubMed ID: 37889325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of photobiomodulation for prevention of oral mucositis on the quality of life of patients with head and neck cancer: a systematic review.
    Potrich AR; Só BB; Schuch LF; Wagner VP; Silveira FM; de Abreu Alves F; Prado-Ribeiro AC; Santos-Silva AR; Treister NS; Martins MD; Martins MAT
    Lasers Med Sci; 2023 Dec; 39(1):1. PubMed ID: 38057605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.
    Anderson CM; Lee CM; Saunders DP; Curtis A; Dunlap N; Nangia C; Lee AS; Gordon SM; Kovoor P; Arevalo-Araujo R; Bar-Ad V; Peddada A; Colvett K; Miller D; Jain AK; Wheeler J; Blakaj D; Bonomi M; Agarwala SS; Garg M; Worden F; Holmlund J; Brill JM; Downs M; Sonis ST; Katz S; Buatti JM
    J Clin Oncol; 2019 Dec; 37(34):3256-3265. PubMed ID: 31618127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study on oral adverse effects in head and neck cancer patients submitted to a preventive oral care protocol.
    Morais MO; Martins AFL; de Jesus APG; de Sousa Neto SS; da Costa AWF; Pereira CH; Oton-Leite AF; de Freitas NMA; Leles CR; Mendonça EF
    Support Care Cancer; 2020 Sep; 28(9):4263-4273. PubMed ID: 31900618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.
    Cripps C; Winquist E; Devries MC; Stys-Norman D; Gilbert R;
    Curr Oncol; 2010 Jun; 17(3):37-48. PubMed ID: 20567625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the NCI-CTCAE version 4.0 and version 3.0 in assessing chemoradiation-induced oral mucositis for locally advanced nasopharyngeal carcinoma.
    Liu YJ; Zhu GP; Guan XY
    Oral Oncol; 2012 Jun; 48(6):554-9. PubMed ID: 22289637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer.
    Giralt J; Tao Y; Kortmann RD; Zasadny X; Contreras-Martinez J; Ceruse P; Arias de la Vega F; Lalla RV; Ozsahin EM; Pajkos G; Mazar A; Attali P; Bossi P; Vasseur B; Sonis S; Henke M; Bensadoun RJ
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):320-328. PubMed ID: 31669562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment.
    Lozano A; Marruecos J; Rubió J; Farré N; Gómez-Millán J; Morera R; Planas I; Lanzuela M; Vázquez-Masedo MG; Cascallar L; Giralt J; Escames G; Valentí V; Grima P; Bosser R; Tarragó C; Mesía R
    Clin Transl Oncol; 2021 Sep; 23(9):1801-1810. PubMed ID: 33738704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
    Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
    Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.
    Hes C; Desilets A; Tonneau M; El Ouarzadi O; De Figueiredo Sousa M; Bahig H; Filion É; Nguyen-Tan PF; Christopoulos A; Benlaïfaoui M; Derosa L; Alves Costa Silva C; Ponce M; Malo J; Belkad W; Charpentier D; Aubin F; Hamilou Z; Jamal R; Messaoudene M; Soulières D; Routy B
    Oral Oncol; 2024 Jan; 148():106623. PubMed ID: 38006691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Photobiomodulation on Nitrite and Inflammatory Activity in Radiotherapy-Induced Oral Mucositis: A Randomized Clinical Trial.
    Martins AFL; Morais MO; Sousa-Neto SS; Oton-Leite AF; Pereira CH; Valadares MC; Freitas NMA; Batista AC; Leles CR; Mendonça EF
    Lasers Surg Med; 2021 Jul; 53(5):671-683. PubMed ID: 32997817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
    Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
    Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
    Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
    Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.